Clinicopathological factors associated with HER2-positive gastric cancer: A meta-analysis

BACKGROUND: The treatment of patients with advanced gastric cancer remains a most challenging task in the clinical practice. Recently, targeted therapies have significantly impacted the treatment strategy for many common malignancies. The use of trastuzumab, a monoclonal antibody against human epide...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hong-Bo, Liao, Xiao-Feng, Zhang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682803/
https://www.ncbi.nlm.nih.gov/pubmed/29095284
http://dx.doi.org/10.1097/MD.0000000000008437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682803/
https://www.ncbi.nlm.nih.gov/pubmed/29095284
http://dx.doi.org/10.1097/MD.0000000000008437

Ejemplares similares